333 related articles for article (PubMed ID: 11938422)
21. Drug-resistant tuberculosis in Taipei, 1996-1999.
Wang PD; Lin RS
Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317
[TBL] [Abstract][Full Text] [Related]
22. Antituberculosis drug resistance and associated risk factors in the European section of Turkey.
Karabay O; Otkun M; Akata F; Karlikaya C; Tuğrul M; Dündar V
Indian J Chest Dis Allied Sci; 2004; 46(3):171-7. PubMed ID: 15553205
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of antituberculous drug resistance among Mycobacterium tuberculosis isolates recovered at the American University of Beirut Medical Center: 1996-1998 vs 1994-1995.
Araj GF; Itani LY; Kanj NA; Jamaleddine GW
J Med Liban; 2000; 48(1):18-22. PubMed ID: 10881438
[TBL] [Abstract][Full Text] [Related]
25. A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico.
Yang ZH; Rendon A; Flores A; Medina R; Ijaz K; Llaca J; Eisenach KD; Bates JH; Villarreal A; Cave MD
Int J Tuberc Lung Dis; 2001 Apr; 5(4):313-20. PubMed ID: 11334249
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
27. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005).
Aisenberg GM; Jacobson K; Chemaly RF; Rolston KV; Raad II; Safdar A
Cancer; 2005 Dec; 104(12):2882-7. PubMed ID: 16245341
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiological survey on the trend of drug resistance of Mycobacterium tuberculosis complex in Macao during 2001 to 2005].
Cheong SV; Lao UL
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):411-4. PubMed ID: 17673010
[TBL] [Abstract][Full Text] [Related]
29. The emergence of drug-resistant tuberculosis in New York City.
Frieden TR; Sterling T; Pablos-Mendez A; Kilburn JO; Cauthen GM; Dooley SW
N Engl J Med; 1993 Feb; 328(8):521-6. PubMed ID: 8381207
[TBL] [Abstract][Full Text] [Related]
30. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
31. Drug resistance among tuberculosis patients, New York City, 1991 and 1992.
Driver CR; Frieden TR; Bloch AB; Onorato IM
Public Health Rep; 1994; 109(5):632-6. PubMed ID: 7938383
[TBL] [Abstract][Full Text] [Related]
32. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran.
Mirsaeidi MS; Tabarsi P; Farnia P; Ebrahimi G; Morris MW; Masjedi MR; Velayati AA; Mansouri D
Saudi Med J; 2007 Apr; 28(4):544-50. PubMed ID: 17457475
[TBL] [Abstract][Full Text] [Related]
33. Antituberculosis drug resistance surveillance in Kenya, 1995.
Githui WA; Juma ES; van Gorkom J; Kibuga D; Odhiambo J; Drobniewski F
Int J Tuberc Lung Dis; 1998 Jun; 2(6):499-505. PubMed ID: 9626608
[TBL] [Abstract][Full Text] [Related]
34. High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana.
Menner N; Günther I; Orawa H; Roth A; Rambajan I; Wagner J; Hahn H; Persaud S; Ignatius R
Trop Med Int Health; 2005 Dec; 10(12):1215-8. PubMed ID: 16359400
[TBL] [Abstract][Full Text] [Related]
35. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
36. Drug susceptibility profiling of tuberculous meningitis.
Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
[TBL] [Abstract][Full Text] [Related]
37. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003.
Al-Tawfiq JA; Al-Muraikhy AA; Abed MS
Chest; 2005 Nov; 128(5):3229-32. PubMed ID: 16304266
[TBL] [Abstract][Full Text] [Related]
39. Treatment monitoring and prevalence of drug resistance in tuberculosis patients in Tehran.
Bahrmand AR; Velayati AA; Bakayev VV
Int J Tuberc Lung Dis; 2000 Jun; 4(6):544-9. PubMed ID: 10864185
[TBL] [Abstract][Full Text] [Related]
40. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
